Evidence map›Paper›PMID 37199228›Full record

ReviewAnnals of the New York Academy of Sciences2023

Emerging roles of brain tanycytes in regulating blood-hypothalamus barrier plasticity and energy homeostasis.

Hasni Kannangara, Liam Cullen, Sari Miyashita, Funda Korkmaz, Anne Macdonald, Anisa Gumerova, Ronit Witztum, Ofer Moldavski, Steven Sims, Jocoll Burgess and 9 more

Open access · greenAbstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 1 institution in 1 country.

Hasni KannangaraCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Liam CullenCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Sari MiyashitaCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Funda KorkmazCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Anne MacdonaldCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Anisa GumerovaCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Ronit WitztumCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Ofer MoldavskiCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Steven SimsCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Jocoll BurgessCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Tal FrolingerCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Rauf LatifCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Yelena GinzburgCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Daria LiznevaCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Ki GoosensCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Terry F DaviesCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Tony YuenCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Mone ZaidiCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Vitaly RyuCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Icahn School of Medicine at Mount Sinai · US

Funding

Targeting FSH for the Therapy of Osteoporosis, Obesity and NeurodegenerationU19AG060917 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Mone Zaidi · 2019 to 2026
$29.0M
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's DiseaseU01AG073148 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Tony Yuen, Mone Zaidi · 2021 to 2026
$10.6M
Elevated FSH - A Driver for Sex Differences in Alzheimer's DiseaseR01AG074092 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HAROUTUNIAN, VAHRAM, YUEN, TONY · 2021 to 2025
$6.3M
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly FemalesR01AG071870 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KIM, SE-MIN, YUEN, TONY · 2021 to 2025
$3.9M
Thyrotropin Receptor, Thyrotropin and Mechanisms of Bone LossR01DK113627 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DAVIES, TERRY FRANCIS, IQBAL, JAMEEL Z · 2017 to 2020
$2.8M
NIA NIH HHS R01 AG071870NIA NIH HHS R01 AG074092NIA NIH HHS U01 AG073148NIA NIH HHS U19 AG060917NIDDK NIH HHS P30 DK020541NIDDK NIH HHS R01 DK113627NIH HHS R01AG071870NIH HHS U19AG60917
6 · The paper itself

Abstract

Seasonal changes in food intake and adiposity in many animal species are triggered by changes in the photoperiod. These latter changes are faithfully transduced into a biochemical signal by melatonin secreted by the pineal gland. Seasonal variations, encoded by melatonin, are integrated by third ventricular tanycytes of the mediobasal hypothalamus through the detection of the thyroid-stimulating hormone (TSH) released from the pars tuberalis. The mediobasal hypothalamus is a critical brain region that maintains energy homeostasis by acting as an interface between the neural networks of the central nervous system and the periphery to control metabolic functions, including ingestive behavior, energy homeostasis, and reproduction. Among the cells involved in the regulation of energy balance and the blood-hypothalamus barrier (BHB) plasticity are tanycytes. Increasing evidence suggests that anterior pituitary hormones, specifically TSH, traditionally considered to have unitary functions in targeting single endocrine sites, display actions on multiple somatic tissues and central neurons. Notably, modulation of tanycytic TSH receptors seems critical for BHB plasticity in relation to energy homeostasis, but this needs to be proven.

Indexed as

MelatoninAnimalsBrainEpendymoglial CellsHomeostasisHypothalamusSeasonsThyrotropinMelatoninThyrotropinblood-hypothalamus barriercerebrospinal fluidepidermal growth factor receptorextracellular signal-regulated kinasefibroblast growth factor 21NPYpituitary glycoprotein hormone receptorPOMCtanycyte

Identifiers

PMID37199228
PMCPMC10524199
OpenAlexW4377011085

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.